CAS 1425945-60-3

EHT 1610

CAS: 1425945-60-3

EHT 1610

Purity: ≥98%

Molecular weight: 383.4g/mol

Ref: 54-BUP12501

EHT 1610

CAS: 1425945-60-3

EHT 1610 is a tyrosine kinase inhibitor that is designed to target the activity of the epidermal growth factor receptor (EGFR) and other members of the ErbB family. It has been shown to inhibit proliferation of glioblastoma cells and leukemia cells in vivo through transcriptional regulation. EHT 1610 has also been shown to suppress neurodegenerative diseases in mice by inhibiting the proliferation of hematopoietic cells. In addition, this drug can be used as a pharmacologic probe for investigating protein-protein interactions.

Formula: C₁₈H₁₄FN₅O₂S

Purity: Min. 95%

Molecular weight: 383.4 g/mol

Ref: 3D-AHC94560

EHT 1610

CAS: 1425945-60-3

EHT 1610 (EHT 5372) is a potent inhibitor of DYRK, with an IC50 of 0.36 nM and 0.59 nM for DYRK1A and DYRK1B, respectively.

Formula: C₁₈H₁₄FN₅O₂S

Purity: 98.43%

Color and Shape: Solid

Molecular weight: 383.4

Ref: TM-T15204